Concluding Remarks of Targeting Mitochondria 2019 by Prof. Weissig, President of World Mitochondria Society

ProfWeissig

Our 10th Anniversary World Congress on Targeting Mitochondria has come to an end. As in all the previous years we met again in Berlin, Germany. It appears to me that in the center of the European Plain, mitochondria and their aficionados have found a true home.

On October 28th and 29th we welcomed 285 attendants from all continents, with 37 nationalities, representing both the academia and the industry. During two very long and intense days, over 130 exciting lectures, short oral communications and poster presentations given by both established scientists and young researchers gave an impressive insight into currently ongoing scientific and corporate efforts to eventually find a cure for mitochondrial diseases.

This very successful meeting, and I dare to claim it was the very best we ever had, was made possible by an entire year of careful planning and organizing by Prof. Marvin Edeas and the support of an outstanding Scientific Committee and Advisory Board.

My heartfelt and sincere “Thank You” goes to all involved in setting up this great meeting. We are in particular grateful to the “Father of Mitochondrial Medicine”, Prof Douglas Wallace for his acceptance of our invitation and for opening our conference with the Honorary Lecture about “Mitochondrial Genetics and Human Diseases”. At the end of our conference, Prof. Wallace also gave the concluding remarks, during which he reminded us how far we actually all have come in the field of Mitochondrial Medicine, considering that over 40 years ago nobody even knew about the existence of any connections between mitochondria and human disease. His outlook into the future gave reason to be optimistic and certainly had an energizing effect on all conference participants.

The 10th Conference on Targeting Mitochondria covered in particular four specific areas. Three sessions were dedicated to first, the recent advances on mitochondrial dysfunction and dynamics pertaining to chronic diseases, second to the role mitochondria play for a healthy skin (the largest organ humans have) and third to clinical trials and potential mitochondria-based therapies.

In addition, a mini-symposium at the beginning of the second conference day organized and chaired by Prof. Carsten Culmsee highlighted the role of actin-regulating proteins on mitochondria in health and diseases.

Thank you all for attending Mitochondria 2019 and for your active participation as a speaker, poster presenter or as a helpful and critical commentator during the Q&A sessions. Last but not least I would like to sincerely thank our corporate sponsors for their financial support and for their active participation in our conference. I am already now looking forward to the 11th edition of our World Conference on Targeting Mitochondria and I hope to see many if not all of you again next year. 


Prof Volkmar Weissig
President of World Mitochondria Society

Nice moments: The 10th Anniversary of Targeting Mitochondria 2019 was a success

Targeting-Mitochondria-2019-Congress-moments-Group

On behalf of the World Mitochondria Society, we thank all Speakers and Attendees for this excellent international conference.

 We selected a few pictures of Day 1, Day 2 and Awards. 

Please follow the links below to see the pictures on WMS Facebook page.

If you cannot access the WMS Facebook page, please click here to see the pictures in Flickr.

Abstracts Book & Final Agenda of Targeting Mitochondria 2019 Congress

Abstracts-Book-2019-Cover-3D-small v1

Scientific Agenda

 

Order the Abstracts Book in PDF Format.

The Abstracts Book contains 131 Communications (Orals and Posters) presented during the congress.

abstract book order v2

Who attended Berlin Mitochondria 2019 congress

MitoQ (Sponsor)
L'Oréal (Sponsor)
Nanolive (Sponsor)
Biolog (Sponsor)
RedoxHC (Sponsor)

AbbVie
Adam Mickiewicz University
Akershus University hospital
Alma Mater Studiorum University of Bologna
Beiersdorf AG
Biolog (Sponsor)
Biomedical Center UG
Brandeis Univ
Cardiff University
CEA / IRCM
Charité - Universitätsmedizin Berlin
Charles University
Children's Hospital of Philadelphia
Chinese Academy of Sciences
CNRS - UMR6290 IGDR
Dalhousie University
Defence Science and Technology Laboratory
EA Pharma Co., Ltd.
ENYO Pharma SA
Evotec SE
FREI S.A.
Gemeinschaftspraxis Dr. Martin und Irini Schärfe
German Diabetes Center
Guided Clarity
Hebrew University
IMDiK, PAN
Indian Institute of Technology Madras
INIBIC-HOSPITAL UNIVERSITARIO A CORUÑA
INRA
INSERM
Institute of Physiology CAS
Instituto de Catálisis y Petroleoquímica, CSIC
IPAC RAS
JAPAN TOBACCO INC.
Johns Hopkins University
Jožef Stefan Institute
JSS Academy Of Higher Education & Research
Justus Liebig Universität
Justus Liebig University of Giessen
Karolinska Institute
Kdc lukina
KU Leuven
Kyoto University
Kyungpook National University
Lodz University of Technology
Lomonosov Moscow State University
Luca Science Inc.
Maastricht University
Masaryk Memorial Cancer Institute
Mayo Clinic
McGill University
MDC Berlin
Medical University Graz
Midwestern University
Mitobiomedical/BiomedicalCenter
Mitochon Pharmaceuticals
MitoImmune Therapeutics Inc.
Mossakowski Medical Research Centre
mse Pharmazeutika GmbH
mvr cancer hospital and research institute
Namik Kemal University
Nanjing Agricultural University
National University of Singapore
Nencki Institute of Experimental Biology
Nestle Research
Nutricia reearch
Ochsner Health System
Odessa national medical university


Osaka Univ., ISIR
Palacky University
Paulig Eye Clinic
Pavol Jozef Safarik University in Kosice
Philipps University of Marburg
Pirogov Russian National Research Medical University
PJ Safarik University
Polish Academy of Sciences
Praxis für Praevention- Stressmedizin- Stoffwechsel
QED Radiations
REGEnLIFE

Rice University
Russian Academy of Sciences
Seoul National University
Shanghai Jiaotong University School of Medicine
Stealth BioTherapeutics
Stellenbosch University
SUNGKYUNKWAN University
Temple University
The Chinese University of Hong Kong
The University of Warwick
Thermo Fisher Scientific - Molecular Probes
Tulane University
Ulm University
UMR 7156 CNRS / Université de Strasbourg
UMR 7156 Strasbourg University - CNRS
Univeristy of South Florida
Università degli Studi dell'Aquila  - Dip. MESVA
Università degli studi di Torino
Universität Graz
Universitätsklinikum Essen
Universitätsmedizin Göttingen
Université Nice Côte d'Azur
University College Cork
University Hospital Regensburg
University Hospital Zürich
University Medical Centre
University Miguel Hernández de Elche-UMH
University Of  Ulsan College Of Medicine
University of Applied Sciences Albstadt-Sigmaringen
University of Barcelona
University of Bath
University of Bergen UiB
University of Bologna
University of Brescia
University of California San Francisco
University of Cambridge
University of Coimbra
University of Giessen
University of Glasgow
University of Groningen
University of Helsinki
University of Malta
University of Marburg
University of Maribor
University of Milan
University of North Texas Health Science Center
University of Oslo
University of Plymouth
University of Queensland
university of Seoul
University of Sheffield
University of Stuttgart
University of Tasmania
university of Texas at Arlington
University of Texas Health Science Center at Houston
University of Ulsan
University of Zagreb
University Witten-Herdecke
Universty of São Paulo
UT MD Anderson Cancer Center
Wayne State University

Last updated September 27, 2019

Pictures of Targeting Mitochondria 2018

 Pictures-WMS-2017  Pictures-WMS-2018